Medical/Pharmaceuticals

AI Meets Audit Powerhouse: Qualifyze Launches Quality Insights Platform to Help Global Pharma Manage Supplier Site Risk

FRANKFURT, Germany, May 29, 2025 /PRNewswire/ -- Qualifyze, already the global leader in third-party audit services for the pharmaceutical industry, announces the launch ofQuality Insights Platform, an AI-powered platform that transforms the world's largest pharmaceutical audit database into a st...

2025-05-29 18:23 2322

The Brain Prize: HM The King of Denmark presents prestigious prize to US and German scientists for seminal discoveries in brain cancer

Two pioneering scientists received The Brain Prize 2025 for their discoveries that open an entirely new way of thinking about and understanding brain cancers, and the potential strategies to treat them. COPENHAGEN, Denmark, May 29, 2025 /PRNewswire/ -- HM King Frederik of Denmark presented neur...

2025-05-29 15:00 2001

CPHI & PMEC China Sees Surge in International Attendance as Global Pharma Trade Outlook Strengthens

Record international participation reflects renewed momentum in pharma manufacturing and global sourcing, as easing tariffs fuel growth SHANGHAI, May 29, 2025 /PRNewswire/ -- CPHI & PMEC China  (June 24-26th) returns to the Shanghai New International Expo Center am...

2025-05-29 12:43 2334

Innovent Announces a Phase 3 Study of Picankibart (Anti-IL-23p19 Antibody) Completes First Participant Dosing, Exploring Biologics Switching Treatment for Psoriasis Patients with Prior Inadequate Response to Anti-IL-17 Antibodies

SAN FRANCISCO and SUZHOU, China, May 29, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic...

2025-05-29 10:23 2803

IonOpticks Generation 4 Aurora Series® sets a new benchmark in chromatography

MELBOURNE, Australia, May 29, 2025 /PRNewswire/ -- IonOpticks , developer of the highest-performing chromatography columns for mass spectrometry research, today announces the launch of its 4th Generation of Aurora Series columns. Following extensive testing by leading pr...

2025-05-29 05:00 1825

Metabolon's Untargeted Metabolomics Services Used for Landmark Study Linking a Western Dietary Pattern During Pregnancy to Neurodevelopment Disorders

Metabolomic profiling uncovered how maternal diet and metabolism may contribute to the risk of ADHD and autism in children MORRISVILLE, N.C., May 28, 2025 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, di...

2025-05-28 21:00 1836

Long-term Commitment to Treating Endometriosis and Improving Women's Quality of Life – Gedeon Richter at the World Congress on Endometriosis

SYDNEY, May 28, 2025 /PRNewswire/ --Gedeon Richter had a strong presence at the World Congress of Endometriosis held this year in Sydney, Australia between 21-24 May 2025. As a Platinum Sponsor Gedeon Richter could reaffirm its inn...

2025-05-28 20:21 1694

NX China Acquires GDP Certification for Shanghai and Lianyungang Facilities

- Establishing High-quality Pharmaceutical Logistics Service Systems - TOKYO, May 28, 2025 /PRNewswire/ -- Nippon Express (China) Co., Ltd. (hereafter "NX China"), a group company of NIPPON EXPRESS HOLDINGS, INC., has received Good Distribution Practice (GDP) certification for air and ocean frei...

2025-05-28 15:00 2422

EpiVax Appoints Dr. Vibha Jawa to Lead Scientific Strategy as CSO

PROVIDENCE, R.I., May 28, 2025 /PRNewswire/ -- EpiVax, Inc., a leader in preclinical immunogenicity assessment for biologic therapeutics and vaccines, is pleased to announce the appointment ofVibha Jawa, PhD, FAAPS as Chief Scientific Officer. Dr. Jawa succeeds EpiVax founder and Executive Chairw...

2025-05-28 14:13 2338

Experimental Drug Development Centre Granted U.S. FDA Fast Track Designation for Antibody-Drug Conjugate EBC-129 to Treat Pancreatic Ductal Adenocarcinoma

* EBC-129 is the first made-in-Singapore antibody-drug conjugate (ADC) to enter clinical development. It selectively targets a tumour-specific N-glycosylated epitope on both CEACAM5 and CEACAM6.  * The Fast Track Designation highlights the potential of EBC-129 to address critical unmet needs ...

2025-05-28 14:00 2029

2025 World Brain Day Dedicated to Brain Health for All Ages

LONDON, May 28, 2025 /PRNewswire/ -- The World Federation of Neurology (WFN) is pleased to announce Brain Health for All Ages as the theme for the 2025 World Brain Day (WBD 2025), taking place on Tuesday, July 22. This global campaign aims to raise awareness of the importance of supporting brain ...

2025-05-28 13:00 1306

Perennial Holdings Signs Agreement with Guangzhou Metro to Establish the First Wholly Foreign-Owned Tertiary General Hospital in Guangzhou and Southern China

SINGAPORE, May 28, 2025 /PRNewswire/ -- Perennial Holdings Private Limited (" Perennial Holdings") entered into an agreement with Guangzhou Metro Group Co. Ltd ("Guangzhou Metro"), where Perennial Holdings will lease approximately 105,000 square metres of space and invest approximatelyRMB1 billion...

2025-05-28 12:18 3169

Exclusive Global 20 Seats, China's Sole One! KT-939 Was Successfully Selected for 2025 NYSCC Inspiration Hive Zone

SUZHOU, China, May 28, 2025 /PRNewswire/ -- In the newly announced entry list of the Inspiration Hive zone at the 2025 New York Society of Cosmetic Chemists (NYSCC) exhibition, Kintor's innovative ingredient KT-939 has been selected as the only "Chinese Ingredient" among the numerous global ones....

2025-05-28 11:08 2151

HKSH Fosters Collaboration for Innovation at Asia Summit on Global Health 2025, Through Partnership with United Imaging to Elevate Medical Imaging Excellence

HONG KONG, May 27, 2025 /PRNewswire/ -- The HKSH Medical Group (HKSH) has for over a century been committed to acquiring the state-of-the-art, world-class technology and facilities to deliver excellent and advanced medical services. Mr. Wyman LI, Chief Operating Officer of HKSH Medical Group, Dire...

2025-05-27 21:00 3073

United Imaging and HKSH Medical Group Establish Strategic Partnership to Elevate Imaging Excellence

HONG KONG, May 27, 2025 /PRNewswire/ -- United Imaging and HKSH Medical Group announced on Monday the signing of a Memorandum of Understanding (MOU), marking a significant step forward in fostering innovation and shared commitment. The signing ceremony was held during the Asia Summit Global Healt...

2025-05-27 19:15 1976

RemeGen: Telitacicept for the Treatment of Generalized Myasthenia Gravis Approved in China

YANTAI, China, May 27, 2025 /PRNewswire/ -- On May 27, RemeGen Co., Ltd.(688331.SH / 09995.HK) announced that Telitacicept has officially been approved for marketing in China by the National Medical Products Administration (NMPA) for the treatment of adult patients with anti-acetylcholine recepto...

2025-05-27 16:30 2256

Alma Unveils Alma IQ at Eighth Global Alma Academy in Dubrovnik

The next-generation skin analysis platform, set to redefine the aesthetic consultation experience CAESAREA, Israel, May 27, 2025 /PRNewswire/ -- Alma , a Sisram Medical company and a global leader in energy-based medical and aesthetic solutions, has officially launchedA...

2025-05-27 07:00 2094

May 19: World Inflammatory Bowel Disease Day | Healthy Gut, Happy Life

SHENZHEN, China, May 26, 2025 /PRNewswire/ -- May 19 is designated as World Inflammatory Bowel Disease (IBD) Day, aimed at raising public awareness of IBD patients and improving their quality of life and medical care. The European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA),...

2025-05-26 21:24 2281

Esaote: The new MyLab™Heron ultrasound scanner for veterinary physicians had its world premiere at the SCIVAC Rimini 2025 Congress

GENOA, Italy, May 26, 2025 /PRNewswire/ -- Esaote, a leading company in the field of medical diagnostic imaging, has presented the world premiere of the new MyLab™Heronultrasound system at the Congress organized in Rimini from May 23 to 25 Mayby SCIVAC, the largest Veterinary Scientific Society in...

2025-05-26 18:00 2265

Abbisko Therapeutics Receives CDE Approval of Breakthrough Therapy Designation for Irpagratinib (ABSK011) in the Treatment of HCC

SHANGHAI, May 26, 2025 /PRNewswire/ -- Abbisko Therapeutics (HKEX Code: 02256) announced that its self-developed, highly selective small molecule FGFR4 inhibitor, irpagratinib (ABSK011), has received approval of Breakthrough Therapy Designation from the Center for Drug Evaluation (CDE) of the Chi...

2025-05-26 12:15 3043
1 ... 46474849505152 ... 396